Official website for Published Impact Analyses for decisions announced by the Australian Government, Ministerial Forums and National Standard Setting Bodies.
Remaking of Sunsetting Instruments without significant amendments – Department of Health
On 28 September, the Department of Health remade without significant amendments a number of Standards and Instruments for human cell and tissue (HCT) products, blood and blood components, which were due to sunset on 1 October 2021. The instruments comprise:
Remaking of Sunsetting Instrument without Significant Amendments – Australian Securities and Investments Commission
On 27 September 2021, the Australian Securities and Investments Commission (ASIC) remade with only minor amendments Class Order [CO 11/272] Substantial holding disclosure: securities lending and prime broking, which was due to sunset on 1 October 2021. The newly remade ASIC Corporations (Securities Lending Arrangements) Instrument 2021/821 will now self-repeal on 1 October 2026.
Regulation Impact Statement – Australian Prudential Regulation Authority
On 20 September 2021, the Australian Prudential Regulation Authority (APRA) announced final reporting standards to address critical data gaps in the current reporting framework.
National Electricity Amendment (Primary Frequency Response Incentive Arrangements) Rule 2021
Decided by
Australian Energy Market Commission
Problem being addressed
The performance of system frequency control during normal power system operation is being negatively affected by disincentives to the provision of primary frequency response from generators.
Remaking of Sunsetting Instrument without significant amendments – Department of Health
On 23 September 2021, the Department of Health remade without significant amendments the Restricted Medicine Specification 2011, which was due to sunset on 1 October 2021. The newly made Therapeutic Goods (Restricted Medicines) Specification 2021 will sunset on 1 October 2031.
The Specification specifies medicines or classes of medicines for the purpose of the definition of ‘restricted medicine’ in subsection 3(1) of the Therapeutic Goods Act 1989, for which a Product Information document is required to be submitted to the Therapeutic Goods Administration as part of an application for registration.
Department/Agency
Australian Building Codes Board
Decided by
Building Ministers
Problem being addressed
The residential building sector is a major source of energy demand and use. While Australia has made considerable progress in the energy performance of residential buildings, there is still opportunity to implement actions that could further reduce the energy consumption of the sector.
Regulation Impact Statement – Department of Industry, Science, Energy and Resources
On 2 September 2021, the Australian Government introduced the Offshore Electricity Infrastructure Bill 2021 into Parliament.
Australia’s current regulatory environment does not provide a defined approvals pathway or protections for proponents looking to establish offshore electricity infrastructure facilities in Commonwealth waters, leading to a number of risks.
The RIS examines options to increase clarity in the regulatory environment to support an efficient and effective offshore electricity undertaking, throughout construction, operation and decommissioning.
Independent Review – Department of Health
Remaking of Sunsetting Instrument without Significant Amendments – Australian Securities and Investments Commission
On September 8, the Australian Securities and Investments Commission (ASIC) remade with only minor amendments the ASIC Corporations (Employee redundancy funds relief) Instrument 2015/1150, which was due to sunset on 1 October 2021. The newly remade ASIC Corporations (Employee redundancy funds relief) Instrument 2021/767 will now sunset on 1 October 2024.
Agency
Australian Transport Safety Bureau
Announcement date
6 September 2021
Problem being addressed